Kendamil Study
醫藥
免費 · 專為 iPad 設計
Welcome to the Kendamil Study:
The Kendamil app is a proprietary platform of ObvioHealth being used to
manage a trial to study use of an investigational infant formula and how it
affect infant growth and tolerance in comparison to current market formula.
The Kendamil app removes the costly overhead of physical site visits and
brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to
completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A subject who is identified as eligible for this study during pre-screening will
be invited to download the Kendamil App via e-mail.
Upon download, the participants create an account and complete the
Informed Consent process. A series of screens explains the parameters of
the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will have the opportunity to connect with a member of the study
team to ask questions prior to signing the informed consent form.
Intervention Period: Daily Tasks
Subjects will contribute data to the study by completing questionnaires and
data uploads over a 7-day baseline period and 16-week active trial period.
Subjects can interact with the study team via secure chat as needed.
評分與評論
此App未收到足夠的評分或評論以顯示概況。
- Bug fixes and Chat feature related improvements
開發者Obvio Health USA Inc.表明App的私隱慣例或包括下列資料的處理。詳情請參閲 開發者的私隱政策 。
不收集資料
開發者不會從此 App 收集任何資料。
輔助使用
開發者尚未表示此 App 支援哪些輔助使用功能。 進一步了解
資料
- 供應商
- OBVIO HEALTH USA
- 大小
- 42.1 MB
- 類別
- 醫藥
- 相容性
須使用 iOS 13.0 或以上版本。
- iPhone
須使用 iOS 13.0 或以上版本。 - iPad
須使用 iPadOS 13.0 或以上版本。 - iPod touch
須使用 iOS 13.0 或以上版本。 - Mac
須使用 macOS 11.0 或以上版本及配備 Apple M1 或以上版本晶片的 Mac。
- 語言
日文及另外3種
- 日文、法文、英文、西班牙文
- 年齡分級
4+
- 4+
- 版權
- © Obvio Health 2023